Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma × Dasatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Leukemia, Myeloid, Chronic-Phase 16 Leukemia 9 Breast Neoplasms 9 Prostatic Neoplasms 8 Neoplasm Metastasis 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Recurrence 5 Philadelphia Chromosome 4 Pancreatic Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Melanoma 3 Lung Neoplasms 3 Burkitt Lymphoma 3 Blast Crisis 3 Triple Negative Breast Neoplasms 2 Salivary Gland Neoplasms 2 Polycythemia Vera 2 Ovarian Neoplasms 2 Neuroblastoma 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Gliosarcoma 2 Glioblastoma 2 Gastrointestinal Stromal Tumors 2 Fallopian Tube Neoplasms 2

Interventions

Cisplatin 19 Paclitaxel 15 Carboplatin 15 Gemcitabine 12 pembrolizumab 11 Fluorouracil 8 Specimen Handling 7 Radiotherapy 7 Nivolumab 6 Magnetic Resonance Spectroscopy 6 Docetaxel 6 cemiplimab 5 Sunitinib 5 Platinum 5 Oxaliplatin 5 Everolimus 5 Cyclophosphamide 5 Capecitabine 5 durvalumab 4 anlotinib 4 Radiotherapy, Intensity-Modulated 4 Pemetrexed 4 Drug Therapy 4 Cetuximab 4 1,2-diaminocyclohexaneplatinum II citrate 4 padeliporfin 3 epothilone B 3 atezolizumab 3 Panitumumab 3 Leucovorin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00564876 2015-02-23

TOP0706

Duke University

Phase 2 Terminated

2 enrolled 4 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡